Which Weight Loss Injection Suits Your Week 13-16 Stage?
Wegovy 1.7mg Price UK vs Mounjaro: Head-to-Head Treatment Comparison
When evaluating Wegovy 1.7mg price UK options against Mounjaro, you're comparing two fundamentally different approaches to weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, while Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors for dual hormonal action. At the 1.7mg stage, you're 13-16 weeks into your Wegovy journey, approaching the final dose escalation before 2.4mg maintenance.
The pricing structures differ significantly between these treatments. Wegovy 1.7mg costs £139.99 at EverydayMeds, representing weeks 13-16 of a structured five-dose escalation protocol. Mounjaro follows a six-dose escalation from 2.5mg to 15mg, with different pricing at each stage. Both medications require prescription-only medicine status and clinical assessment, but their dose timing and escalation schedules create different cost patterns throughout your treatment journey.
Wegovy 1.7mg Price UK: Transparent Pricing and Bundle Value
Our Wegovy 1.7mg price UK stands at £139.99 per pen, with discount codes applied at checkout to reach this final price. New customers use code FIRST40, while returning customers apply DOSE25 during checkout. The Consistency 1.7mg bundle provides two pens for £309.99, offering supply security for patients who need extended time at this dose before progressing to maintenance.
For seamless transition planning, our Elevate Duo combines 1.7mg and 2.4mg pens for £369.99, preparing you for maintenance dosing. This bundle approach eliminates multiple ordering cycles and ensures continuous supply during your critical progression phase. All prices include VAT and reflect final customer costs after discount application, with no hidden fees or subscription requirements affecting your Wegovy 1.7mg price UK calculation.
Clinical Evidence Behind Wegovy 1.7mg Price UK Effectiveness
The STEP clinical trial programme, published by Wilding et al. in the New England Journal of Medicine (2021), demonstrated that patients taking Wegovy alongside diet and exercise experienced approximately 15% average weight loss at 68 weeks. The 1.7mg dose represents a crucial escalation point where many patients report enhanced appetite control and satiety signals becoming more pronounced.
Comparative studies suggest that both Wegovy and Mounjaro may support significant weight management when used as prescribed, though direct head-to-head trials remain limited. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events with semaglutide, adding potential heart health benefits to weight management outcomes for eligible patients.
How Wegovy 1.7mg Mechanisms Justify UK Price Investment
Understanding Wegovy's mechanism helps contextualize the 1.7mg price UK within your treatment investment. Semaglutide acts as a GLP-1 receptor agonist, binding to receptors in your brain's appetite control centres and digestive system. This dual action may reduce food cravings, slow gastric emptying, and enhance feelings of fullness after smaller meals. The 1.7mg dose provides higher semaglutide concentrations than previous escalation steps, potentially intensifying these beneficial effects. At this stage, many patients report more consistent appetite control and reduced food preoccupation compared to earlier doses.
Streamlined Ordering Process for Wegovy 1.7mg Price UK Access
Accessing Wegovy at our competitive 1.7mg price UK requires completion of a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (24-hour express review available), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, your Wegovy ships via next-day delivery in temperature-controlled packaging, maintaining cold-chain integrity from our GPhC-registered facility (#9012878) to your door. Payment processing occurs only after prescriber approval, guaranteeing you pay our Wegovy 1.7mg price UK only for medications you're clinically suitable to receive.
Storage Advantages: Wegovy 1.7mg Price UK vs Mounjaro Practicality
Storage requirements significantly impact the practical value of your Wegovy 1.7mg price UK investment compared to Mounjaro alternatives. Wegovy pens maintain potency for up to 6 weeks at room temperature below 30°C once removed from refrigeration, while Mounjaro requires return to refrigeration within 21 days. This storage advantage makes Wegovy more suitable for travel, work schedules, or households with limited refrigerator space. The FlexTouch pen design delivers consistent doses with audible click confirmation, and the longer room-temperature stability reduces waste risk if you forget refrigeration temporarily.
Dose Escalation Economics: Wegovy 1.7mg Price UK in Treatment Context
The Wegovy 1.7mg price UK reflects your position in a structured five-dose escalation protocol designed to minimize side effects while optimizing therapeutic benefits. Unlike Mounjaro's six-dose schedule extending to 15mg maximum, Wegovy's approach reaches maintenance at 2.4mg, creating different long-term cost projections. Patients at 1.7mg typically spend 4 weeks at this dose before progressing to maintenance, making the £139.99 investment your penultimate escalation expense.
Monthly maintenance costs differ between treatments, with Wegovy 2.4mg at £209.99 compared to varying Mounjaro maintenance doses. The recently MHRA-approved 7.2mg Wegovy dose (not yet available at EverydayMeds) may provide future escalation options for patients requiring additional therapeutic support beyond standard maintenance protocols.
Expert Guidance: Choosing Between Wegovy 1.7mg Price UK and Mounjaro Investment
EverydayMeds stocks both Wegovy and Mounjaro because optimal treatment varies by individual patient factors including response patterns, side effect tolerance, and lifestyle requirements. Our prescribers consider your medical history, previous GLP-1 experience, and treatment goals when recommending between single or dual receptor targeting. The Wegovy 1.7mg price UK represents investment in proven semaglutide therapy, while Mounjaro offers tirzepatide's dual mechanism approach. Both require commitment to reduced-calorie diet and increased physical activity for optimal results. Your prescriber can help determine which treatment mechanism and cost structure align with your weight management strategy and budget planning. Apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing on either treatment option.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
